Pathology Department, Animal and Plant Health Agency (APHA), Woodham Lane, New Haw, Addlestone, KT15 3NB, UK.
Department of Viroscience, Erasmus Medical Centre, Rotterdam, The Netherlands.
Sci Rep. 2020 Dec 14;10(1):21894. doi: 10.1038/s41598-020-78949-0.
The rapid emergence of SARS-CoV-2, the causative agent of COVID-19, and its dissemination globally has caused an unprecedented strain on public health. Animal models are urgently being developed for SARS-CoV-2 to aid rational design of vaccines and therapeutics. Immunohistochemistry and in situ hybridisation techniques that facilitate reliable and reproducible detection of SARS-CoV and SARS-CoV-2 viral products in formalin-fixed paraffin-embedded (FFPE) specimens would be of great utility. A selection of commercial antibodies generated against SARS-CoV spike protein and nucleoprotein, double stranded RNA, and RNA probe for spike genes were evaluated for the ability to detect FFPE infected cells. We also tested both heat- and enzymatic-mediated virus antigen retrieval methods to determine the optimal virus antigen recovery as well as identifying alternative retrieval methods to enable flexibility of IHC methods. In addition to using native virus infected cells as positive control material, the evaluation of non-infected cells expressing coronavirus (SARS, MERS) spike as a biosecure alternative to assays involving live virus was undertaken. Optimized protocols were successfully applied to experimental animal-derived tissues. The diverse techniques for virus detection and control material generation demonstrated in this study can be applied to investigations of coronavirus pathogenesis and therapeutic research in animal models.
SARS-CoV-2 的迅速出现及其在全球范围内的传播,给公共卫生带来了前所未有的压力。目前正在紧急开发 SARS-CoV-2 的动物模型,以帮助合理设计疫苗和治疗方法。免疫组织化学和原位杂交技术可在福尔马林固定石蜡包埋(FFPE)标本中可靠且可重复地检测 SARS-CoV 和 SARS-CoV-2 病毒产物,这将非常有用。针对 SARS-CoV 刺突蛋白和核蛋白、双链 RNA 以及用于刺突基因的 RNA 探针,选择了一些商业化的抗体进行评估,以确定其检测 FFPE 感染细胞的能力。我们还测试了热诱导和酶诱导的病毒抗原修复方法,以确定最佳的病毒抗原恢复,同时还确定了替代的抗原修复方法,以实现免疫组织化学方法的灵活性。除了使用天然感染病毒的细胞作为阳性对照材料外,还评估了表达冠状病毒(SARS、MERS)刺突蛋白的非感染细胞作为涉及活病毒的检测的生物安全替代物。优化的方案成功应用于实验动物来源的组织。本研究中展示的多种病毒检测和对照材料生成技术可应用于动物模型中冠状病毒发病机制和治疗研究的调查。